Initial testing (stage 1) of the Polo-like kinase inhibitor volasertib (BI 6727), by the Pediatric Preclinical Testing Program.
Pediatr Blood Cancer
; 61(1): 158-64, 2014 Jan.
Article
in En
| MEDLINE
| ID: mdl-23956067
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pteridines
/
Proto-Oncogene Proteins
/
Protein Serine-Threonine Kinases
/
Cell Cycle Proteins
/
Protein Kinase Inhibitors
/
Neoplasms, Experimental
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Pediatr Blood Cancer
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
/
PEDIATRIA
Year:
2014
Type:
Article